Creative Planning’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-19,024
Closed -$273K 4306
2026
Q1
$273K Sell
19,024
-315
-2% -$4.68K ﹤0.01% 3489
2025
Q4
$291K Buy
19,339
+4,872
+34% +$73.1K ﹤0.01% 3262
2025
Q3
$209K Buy
14,467
+3,773
+35% +$53.6K ﹤0.01% 3447
2025
Q2
$152K Sell
10,694
-95
-0.9% -$1.36K ﹤0.01% 3324
2025
Q1
$161K Sell
10,789
-1,049
-9% -$16.4K ﹤0.01% 3141
2024
Q4
$170K Buy
+11,838
New +$183K ﹤0.01% 3022
2021
Q2
Sell
-25,250
Closed -$664K 2131
2021
Q1
$664K Hold
25,250
﹤0.01% 1258
2020
Q4
$723K Buy
25,250
+250
+1% +$6.65K ﹤0.01% 1111
2020
Q3
$596K Hold
25,000
﹤0.01% 1048
2020
Q2
$523K Hold
25,000
﹤0.01% 1009
2020
Q1
$448K Buy
+25,000
New +$482K ﹤0.01% 999

Other funds holding BMEZ

Creative Planning's BMEZ Position: Q2 2026 in Review

Creative Planning sold out of BlackRock Health Sciences Trust II (BMEZ) in Q2 2026, closing a stake of 19,024 shares — an estimated $273K sold.

Creative Planning first reported a position in BMEZ in Q1 2020 and held it in 11 quarters. The position peaked at $723K in Q4 2020. 89 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Creative Planning reported no remaining BlackRock Health Sciences Trust II position as of Q2 2026 after selling out during the quarter.
  • Creative Planning sold 19,024 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $273K.
  • Creative Planning first reported a position in BlackRock Health Sciences Trust II in Q1 2020 and held it in 11 quarters.
  • Creative Planning's BlackRock Health Sciences Trust II position peaked at $723K in Q4 2020.
  • 89 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.